IL133731A0 - Certain diarylimidazole derivatives, a new class of npy specific ligands - Google Patents

Certain diarylimidazole derivatives, a new class of npy specific ligands

Info

Publication number
IL133731A0
IL133731A0 IL13373198A IL13373198A IL133731A0 IL 133731 A0 IL133731 A0 IL 133731A0 IL 13373198 A IL13373198 A IL 13373198A IL 13373198 A IL13373198 A IL 13373198A IL 133731 A0 IL133731 A0 IL 133731A0
Authority
IL
Israel
Prior art keywords
certain
new class
specific ligands
npy
diarylimidazole derivatives
Prior art date
Application number
IL13373198A
Other languages
English (en)
Original Assignee
Neurogen Corp
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp, Pfizer filed Critical Neurogen Corp
Publication of IL133731A0 publication Critical patent/IL133731A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13373198A 1997-07-03 1998-07-02 Certain diarylimidazole derivatives, a new class of npy specific ligands IL133731A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5171197P 1997-07-03 1997-07-03
PCT/US1998/013861 WO1999001128A1 (fr) 1997-07-03 1998-07-02 Certains derives diarylimidazoles; nouvelle classe de ligands specifiques de neuropeptide y (npy)

Publications (1)

Publication Number Publication Date
IL133731A0 true IL133731A0 (en) 2001-04-30

Family

ID=21972909

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13373198A IL133731A0 (en) 1997-07-03 1998-07-02 Certain diarylimidazole derivatives, a new class of npy specific ligands

Country Status (13)

Country Link
US (2) US6121260A (fr)
EP (1) EP0996443A1 (fr)
JP (1) JP2002515400A (fr)
KR (1) KR20010020610A (fr)
CN (1) CN1265033A (fr)
AU (1) AU744297B2 (fr)
BR (1) BR9810651A (fr)
CA (1) CA2294898A1 (fr)
HU (1) HUP0003934A3 (fr)
IL (1) IL133731A0 (fr)
NO (1) NO996573L (fr)
PL (1) PL337887A1 (fr)
WO (1) WO1999001128A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590106B2 (en) * 1997-05-09 2003-07-08 Pharm-Eco Laboratories, Inc. Amino acid derivatives and methods of making the same
CA2294898A1 (fr) * 1997-07-03 1999-01-14 Neurogen Corporation Certains derives diarylimidazoles; nouvelle classe de ligands specifiques de neuropeptide y (npy)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
WO2000064880A1 (fr) 1999-04-22 2000-11-02 Synaptic Pharmaceutical Corporation Antagonistes selectifs npy (y5)
WO2000066578A1 (fr) 1999-04-30 2000-11-09 Pfizer Products Inc. Composes pour le traitement de l'obesite
AR024077A1 (es) * 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
AU773892B2 (en) * 1999-06-30 2004-06-10 H. Lundbeck A/S Selective NPY (Y5) antagonists
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
ATE257827T1 (de) 1999-07-21 2004-01-15 Hoffmann La Roche Triazolderivate
DE60022386T2 (de) 1999-12-16 2006-06-22 Schering Corp. Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
ES2236178T3 (es) * 2000-02-22 2005-07-16 Banyu Pharmaceutical Co., Ltd. Nuevos compuestos de imidazolina.
HUP0303829A3 (en) 2001-04-16 2006-02-28 Tanabe Seiyaku Co Large conductance calcium-acitvated k channel opener compounds, use thereof and pharmaceutical compositions containing them
KR20040004705A (ko) * 2001-06-08 2004-01-13 시토비아 인크. 카스파제의 활성제 및 아폽토시스의 유도제로서의 치환된3-아릴-5-아릴-[1,2,4]-옥사디아졸과 유사체 및 이의 용도
US7124183B2 (en) 2001-09-26 2006-10-17 Bell Security Solutions Inc. Method and apparatus for secure distributed managed network information services with redundancy
US20050165011A1 (en) * 2002-05-15 2005-07-28 Gellibert Francoise J. Benzoxazine and benzoxazinone substituted triazoles
US7884120B2 (en) 2002-08-19 2011-02-08 Lorus Therapeutics Inc. 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
US6958347B2 (en) 2002-12-18 2005-10-25 Pfizer Inc. Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
US6949564B2 (en) * 2002-12-18 2005-09-27 Pfizer Inc. NPY-5 antagonists
WO2004058253A1 (fr) * 2002-12-18 2004-07-15 Cytovia, Inc. 3,5-disubstitues-[1,2,4]-oxadiazoles et analogues servant d'activateurs des caspases et de promoteurs de l'apoptose, et leur utilisation
DK1692113T3 (en) 2003-11-14 2018-01-08 Lorus Therapeutics Inc ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES
JP4694251B2 (ja) * 2004-06-10 2011-06-08 四国化成工業株式会社 無鉛半田付け用の銅または銅合金の表面処理剤及びその利用
CN101624374B (zh) * 2004-06-10 2012-03-21 四国化成工业株式会社 在焊接过程中用于铜表面上的苯基萘基咪唑
KR101074640B1 (ko) * 2004-06-10 2011-10-19 시코쿠가세이고교가부시키가이샤 납땜 동안 구리 표면에 사용하기 위한 페닐나프틸이미다졸
AU2006250809B2 (en) 2005-05-25 2011-05-12 Lorus Therapeutics Inc. 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer
TWI387592B (zh) * 2005-08-30 2013-03-01 Novartis Ag 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法
US9447049B2 (en) * 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
TR201903981T4 (tr) 2008-06-16 2019-04-22 Univ Ohio State Res Found Kanser tedavisi için bileşikler.
JP5361316B2 (ja) * 2008-10-02 2013-12-04 株式会社タムラ製作所 表面処理剤、プリント回路基板およびその製造方法
JP5615227B2 (ja) * 2011-05-23 2014-10-29 四国化成工業株式会社 銅または銅合金の表面処理剤及びその利用
JP5858884B2 (ja) * 2012-08-16 2016-02-10 四国化成工業株式会社 チオフェン環を有するイミダゾール化合物
JP5892605B2 (ja) * 2012-08-17 2016-03-23 四国化成工業株式会社 4−(2−チエニル)イミダゾール化合物
US9309247B2 (en) 2013-03-20 2016-04-12 Lorus Therapeutics Inc. 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer
WO2015051302A1 (fr) 2013-10-04 2015-04-09 Aptose Biosciences Inc. Compositions et procédés de traitement de cancers
ES2815374T3 (es) 2014-05-06 2021-03-29 Oncternal Therapeutics Inc Compuestos para el tratamiento del cáncer
CN104974095B (zh) * 2015-06-30 2017-09-15 浙江大学 2,4,5‑多取代咪唑类化合物及制备方法
JP2021501203A (ja) 2017-10-30 2021-01-14 アプトース バイオサイエンシズ インコーポレイテッド がん治療用のアリールイミダゾール
WO2022236253A1 (fr) * 2021-05-03 2022-11-10 Nuvation Bio Inc. Composés hétérocycliques en tant qu'inhibiteurs de kinase
EP4173485A1 (fr) * 2021-10-27 2023-05-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composés inhibant l'agrégation de protéine pour la lutte contre les maladies des plantes
CN115043779B (zh) * 2022-06-14 2024-06-25 广东金柏化学有限公司 一种2,4-二苯基咪唑化合物及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE297816C (fr) *
US3297710A (en) * 1963-04-09 1967-01-10 Du Pont Oxoarylidene-imidazoles
US3657441A (en) * 1970-07-30 1972-04-18 Merck & Co Inc Method of inhibiting the formation of phenylethanolamine n-methyl transferase with imidazoles
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US4134983A (en) * 1975-03-03 1979-01-16 Merck & Co., Inc. 3-amino-2-or-propoxyaryl substituted imidazoles
US4853383A (en) * 1975-03-03 1989-08-01 Merck & Co., Inc. β-blocking substituted imidazoles
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
IT1206498B (it) 1983-07-18 1989-04-27 Angeli Inst Spa Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico.
DE3411997A1 (de) * 1984-03-31 1985-10-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
IN165525B (fr) * 1984-07-23 1989-11-04 Shinetsu Chemical Co
PT80975B (pt) * 1984-08-17 1987-11-11 Shinetsu Chemical Co Processo para a preparacao de um polimero de vinilo
IL83467A0 (en) * 1986-08-15 1988-01-31 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
JP2630432B2 (ja) * 1987-08-24 1997-07-16 コニカ株式会社 新規なシアンカプラーを含有するハロゲン化銀カラー写真感光材料
JP2700475B2 (ja) * 1988-07-30 1998-01-21 コニカ株式会社 非線形光学材料および非線形光学素子
DE3835195A1 (de) * 1988-10-15 1990-04-19 Basf Ag Verfahren zur herstellung von p-nitrophenyl-imidazolen
AU621245B2 (en) * 1989-10-17 1992-03-05 Boehringer Mannheim Gmbh Hydrolase substrates, a process for the preparation thereof and agents containing them
ATE109979T1 (de) * 1990-03-30 1994-09-15 Heumann Pharma Gmbh & Co Verwendung von guanidinderivaten zur herstellung eines arzneimittels mit npy-antagonistischer wirkung.
US5296609A (en) * 1993-04-09 1994-03-22 Syntex Pharmaceuticals, Ltd. Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
TW270944B (fr) * 1993-05-10 1996-02-21 Shikoku Kakoki Co Ltd
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
AU7692996A (en) * 1995-12-01 1997-06-27 Ciba-Geigy Ag Receptor antagonists
CA2294898A1 (fr) * 1997-07-03 1999-01-14 Neurogen Corporation Certains derives diarylimidazoles; nouvelle classe de ligands specifiques de neuropeptide y (npy)

Also Published As

Publication number Publication date
BR9810651A (pt) 2000-10-03
HUP0003934A2 (hu) 2001-11-28
AU744297B2 (en) 2002-02-21
KR20010020610A (ko) 2001-03-15
WO1999001128A1 (fr) 1999-01-14
HUP0003934A3 (en) 2002-01-28
EP0996443A1 (fr) 2000-05-03
PL337887A1 (en) 2000-09-11
US6515133B1 (en) 2003-02-04
AU8286898A (en) 1999-01-25
CN1265033A (zh) 2000-08-30
JP2002515400A (ja) 2002-05-28
CA2294898A1 (fr) 1999-01-14
NO996573L (no) 2000-02-23
NO996573D0 (no) 1999-12-30
US6121260A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
IL133731A0 (en) Certain diarylimidazole derivatives, a new class of npy specific ligands
ZA982853B (en) Nicotinamide derivatives.
ZA989061B (en) Medicaments.
HK1028048A1 (en) 4"-Substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives.
ZA989767B (en) Novel compounds.
ZA988390B (en) Tie ligand homologues.
PT966477E (pt) Derivados 3'-n-oxido, 3'-n-dimetilamina 9-oxima-eritromicina a
ZA985323B (en) New compounds
AUPP003197A0 (en) New heterocyclic compounds
ZA9711728B (en) A face mask.
GB9803410D0 (en) A clog
DK0973397T3 (da) Hidtil ukendt fungicid sammensætning, der omfatter en 2-imidazolin-5-0n
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA984085B (en) A novel salt.
ZA9811758B (en) Novel compounds.
EG21217A (en) A metallogene compounds
ZA982436B (en) Thiazolimine derivatives.
AU5270998A (en) Scroll hydraulic machine
ZA9811503B (en) Novel compounds.
IL136500A0 (en) 1,4-diazacycloheptane derivatives
ZA983736B (en) New compounds
ZA987530B (en) Rotary pumps
GB2325278B (en) Hydraulic vane machine
AU5269798A (en) Scroll hydraulic machine
AUPO622597A0 (en) New heterocyclic compounds